Journal of Diagnostics Concepts & Practice >
Current applications and prospects of visceral fat in obesity diagnosis and comorbidity prediction
Received date: 2024-11-22
Accepted date: 2025-02-08
Online published: 2025-02-25
In 2021, 2.11 billion adults aged 25 and older worldwide were overweight or obese, with China having the highest number at 402 million. By 2050, the global population of overweight or obese adults is projected to rise to 3.8 billion, with China expected to account for 627 million of this total. Moreover, obesity is strongly associated with the occurrence and progression of various diseases, including cardiovascular diseases, cancers, and type 2 diabetes. Thus, the diagnosis and management of obesity have become a major global health challenge. However, traditional body mass index (BMI)-based diagnostic systems exhibit limitations in accurately reflecting abnormal fat distribution and metabolic dysfunction. Excessive visceral fat accumulation has been identified as a key factor in obesity-related metabolic disorders. Notably, visceral fat area (VFA), as an objective and quantifiable indicator for obesity assessment, demonstrates significant correlations with obesity and its comorbidities. Recent studies show that VFA outperforms BMI in the diagnosis and prediction of obesity and its associated comorbidities. Furthermore, VFA demonstrates superior value in evaluating the therapeutic efficacy of different interventions for obesity. Experience from China's Metabolic Management Center (MMC) has demonstrated the clinical value of VFA measured by standardized bioelectrical impedance analysis in obesity diagnosis and clinical mana-gement. In the future, the diagnosis and clinical management of obesity and its comorbidities should integrate multiple assessment methods incorporating multidimensional stratification analysis and personalized precision evaluation to further enhance comprehensive clinical management of obesity.
Key words： Visceral fat; Obesity; Diagnosis; Clinical management
ZHANG Yifei , SHI Juan , XU Yuening . Current applications and prospects of visceral fat in obesity diagnosis and comorbidity prediction[J]. Journal of Diagnostics Concepts & Practice, 2025 , 24(01) : 7 -13 . DOI: 10.16150/j.1671-2870.2025.01.002
| [1] | Obesity: preventing and managing the global epidemic. Report of a WHO consultation[J]. World Health Organ Tech Rep Ser, 2000, 894:i-253. |
| [2] | GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021[J]. Lancet, 2025, 405(10481):813-838. |
| [3] | RUBINO F, CUMMINGS D E, ECKEL R H,et al. Definition and diagnostic criteria of clinical obesity[J]. Lancet Diabetes Endocrinol, 2025, 13(3):221-262. |
| [4] | MANSON J E, WILLETT W C, STAMPFER M J,et al. Body weight and mortality among women[J]. N Engl J Med, 1995, 333(11):677-685. |
| [5] | MILANESE C, ITANI L, CAVEDON V,et al. Revising BMI cut-off points for overweight and obesity in male athletes: an analysis based on multivariable model-building[J]. Nutrients, 2025, 17(5):908. |
| [6] | THOMAS D M, BREDLAU C, BOSY-WESTPHAL A,et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model[J]. Obesity (Silver Spring), 2013, 21(11):2264-2271. |
| [7] | TOKUNAGA K, MATSUZAWA Y, ISHIKAWA K,et al. A novel technique for the determination of body fat by computed tomography[J]. Int J Obes, 1983, 7(5):437-445. |
| [8] | NAULI A M, MATIN S. Why do men accumulate abdominal visceral fat?[J]. Front Physiol, 2019, 10:1486. |
| [9] | WAJCHENBERG B L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome[J]. Endocr Rev, 2000, 21(6):697-738. |
| [10] | KIM E H, KIM H K, LEE M J,et al. Sex differences of visceral fat area and visceral-to-subcutaneous fat ratio for the risk of incident type 2 diabetes mellitus[J]. Diabetes Metab J, 2022, 46(3):486-498. |
| [11] | SATO F, MAEDA N, YAMADA T,et al. Association of epicardial, visceral, and subcutaneous fat with cardiometabolic diseases[J]. Circ J, 2018, 82(2):502-508. |
| [12] | NEELAND I J,LIM S, TCHERNOF A,et al. Metabolic syndrome[J]. Nat Rev Dis Primers, 2024, 10(1):77. |
| [13] | SHI J, BAO G, HONG J,et al. Deciphering CT texture features of human visceral fat to evaluate metabolic disorders and surgery-induced weight loss effects[J]. EBioMedicine, 2021, 69:103471. |
| [14] | LEMIEUX I, DESPRéS J P. Metabolic Syndrome: Past, Present and Future[J]. Nutrients, 2020, 12(11): 3501. |
| [15] | NEELAND I J, ROSS R, DESPRéS J P,et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic di-sease: a position statement[J]. Lancet Diabetes Endocrinol, 2019, 7(9):715-725. |
| [16] | HU H H, NAYAK K S, GORAN M I. Assessment of abdominal adipose tissue and organ fat content by magnetic resonance imaging[J]. Obes Rev, 2011, 12(5):e504-e515. |
| [17] | SHUSTER A, PATLAS M, PINTHUS J H,et al. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis[J]. Br J Radiol, 2012, 85(1009):1-10. |
| [18] | CHEUNG A S, DE ROOY C, HOERMANN R,et al. Correlation of visceral adipose tissue measured by Lunar Prodigy dual X-ray absorptiometry with MRI and CT in older men[J]. Int J Obes (Lond), 2016, 40(8):1325-1328. |
| [19] | LUKASKI H C, JOHNSON P E, BOLONCHUK W W,et al. Assessment of fat-free mass using bioelectrical impedance measurements of the human body[J]. Am J Clin Nutr, 1985, 41(4):810-817. |
| [20] | KYLE U G, BOSAEUS I, DE LORENZO A D,et al. Bioe-lectrical impedance analysis--part Ⅰ: review of principles and methods[J]. Clin Nutr, 2004, 23(5):1226-1243. |
| [21] | OMURA-OHATA Y, SON C, MAKINO H,et al. Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes[J]. Cardiovascular Diabetology, 2019, 18(1): 137. |
| [22] | RYO M, MAEDA K, ONDA T,et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance[J]. Diabetes Care, 2005, 28(2):451-453. |
| [23] | Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan[J]. Circ J, 2002, 66(11):987-992. |
| [24] | 中华医学会内分泌学分会. 肥胖患者的长期体重管理及药物临床应用指南(2024版)[J]. 中华内分泌代谢杂志, 2024, 40(7):545-564. |
| Chinese Society of Endocrinology. Guideline for chronic weight management and clinical practice of anti-obesity medications(2024 version)[J]. Chin J Endocrinol Metab, 2024, 40(7):545-564. | |
| [25] | 《中国心血管病研究》杂志编辑委员会, 中国未来研究会未来生物医学工程分会心肾代谢性疾病防治学组, 夏经钢,等. 心血管-肾脏-代谢综合征患者的综合管理中国专家共识[J]. 中国心血管病研究, 2025, 23(3):193-228. |
| The Editorial Committee of Chinese Journal of Cardiovascular Research, Heart-Renal-Metabolic Disease Prevention and Treatment Group, Future Biomedical Enginee-ring Branch, China Future Research Association, XIA J G,et al. Chinese expert consensus on comprehensive management of patients with cardiovascular-kidney-metabolic syndrome[J]. Chin J Cardiovasc Dis, 2025, 23(3):193-228. | |
| [26] | 中华医学会内分泌学分会, 中华中医药学会糖尿病分会, 中国医师协会外科医师分会肥胖和糖尿病外科医师委员会, 等. 基于临床的肥胖症多学科诊疗共识（2021年版）[J]. 中华消化外科杂志, 2021, 20(11):1137-1152. |
| Chinese Society of Endocrinology, Diabetes Society of China Association of Chinese Medicine, Chinese Society for Metabolic and Bariatric Surgery, et al. Multidisciplinary clinical consensus on diagnosis and treatment of obesity (2021 edition)[J]. Chin J Dig Surg, 2021, 20(11):1137-1152. | |
| [27] | HUO L, LI K, DENG W,et al. Optimal cut-points of visceral adipose tissue areas for cardiometabolic risk factors in a Chinese population: a cross-sectional study[J]. Diabet Med, 2019, 36(10):1268-1275. |
| [28] | LU F, FAN J, LI F,et al. Abdominal adipose tissue and type 2 diabetic kidney disease: adipose radiology assessment, impact, and mechanisms[J]. Abdom Radiol (NY), 2024, 49(2):560-574. |
| [29] | GóMEZ-AMBROSI J, GONZáLEZ-CRESPO I, CATALáN V,et al. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities[J]. Clin Nutr, 2018, 37(2):580-589. |
| [30] | SAPONARO C, SABATINI S, GAGGINI M,et al. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals[J]. Liver Int, 2022, 42(11):2418-2427. |
| [31] | TALLAM H, ELTON D C, LEE S,et al. Fully automated abdominal CT biomarkers for type 2 diabetes using deep learning[J]. Radiology, 2022, 304(1):85-95. |
| [32] | HE J, ZHANG B, FAN Y,et al. Comparison of bioelectrical body and visceral fat indices and anthropometric measures in relation to type 2 diabetes by sex among Chinese adults, a cross-sectional study[J]. Front Public Health, 2023, 11:1001397. |
| [33] | RUI-HUA C, YI L, HUAN-BAI X,et al. Sex differences of visceral fat with cardiac structure and function in type 2 diabetes: A cross-sectional study[J]. J Diabetes, 2024, 16(11):e70023. |
| [34] | HUA S, YAO D, WU S,et al. Association between visceral fat area and diabetic retinopathy among people with type 2 diabetes mellitus: a cross-sectional study in Ningbo, Zhejiang Province, China[J]. Front Med (Lausanne), 2024, 11:1327805. |
| [35] | ZHAO P, LI Q, DU T,et al. Association of different obesity indexes with diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study[J]. Sci Rep, 2024, 14(1):21571. |
| [36] | LEE H S, LEE J. Effects of exercise interventions on weight, body mass index, lean body mass and accumulated visceral fat in overweight and obese individuals: a systematic review and meta-analysis of randomized controlled trials[J]. Int J Environ Res Public Health, 2021, 18(5):2635. |
| [37] | WANG X, WANG S, ZHONG L,et al. Mobile-based platform with a low-calorie dietary intervention involving prepackaged food for weight loss for people with overweight and obesity in China: half-year follow-up results of a randomi-zed controlled trial[J]. JMIR Mhealth Uhealth, 2024, 12:e47104. |
| [38] | KHALAFI M, SYMONDS M E, MALEKI A H,et al. Combined versus independent effects of exercise training and intermittent fasting on body composition and cardiometabolic health in adults: a systematic review and meta-analysis[J]. Nutr J, 2024, 23(1):7. |
| [39] | KADOWAKI T, NISHIDA T, OGAWA W,et al. Effect of once-weekly subcutaneous semaglutide on abdominal visceral fat area in Japanese adults with overweight and obesity: A post hoc analysis of the STEP 6 trial[J]. Obes Res Clin Pract, 2025, 19(2):146-153. |
| [40] | KIM M K, JANG E H, SON J W,et al. Visceral obesity is a better predictor than generalized obesity for basal insulin requirement at the initiation of insulin therapy in patients with type 2 diabetes[J]. Diabetes Res Clin Pract, 2011, 93(2):174-178. |
| [41] | CUI B, DUAN J, ZHU L,et al. Effect of laparoscopic sleeve gastrectomy on mobilization of site-specific body adipose depots: a prospective cohort study[J]. Int J Surg, 2023, 109(10):3013-3020. |
| [42] | YU H, DI J, BAO Y,et al. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2 [J]. Surg Obes Relat Dis, 2015, 11(1):6-11. |
| [43] | IMAI Y, LEE S W, KAWAI M,et al. Visceral fat area is a better indicator of surgical outcomes after laparoscopic gastrectomy for cancer than the body mass index: a propensity score-matched analysis[J]. Surg Endosc, 2022, 36(5):3285-3297. |
| [44] | ZHAI W, YANG Y, ZHANG K,et al. Impact of visceral obesity on infectious complications after resection for colorectal cancer: a retrospective cohort study[J]. Lipids Health Dis, 2023, 22(1):139. |
| [45] | INOUE Y, ISHII M, FUJII K,et al. Safety and efficacy of laparoscopic liver resection for colorectal liver metastasis with obesity[J]. Am Surg, 2021, 87(6):919-926. |
| [46] | ZHAO L, ZHOU X, CHEN Y,et al. Association of visceral fat area or BMI with arterial stiffness in ideal cardiovascular health metrics among T2DM patients[J]. J Diabetes, 2024, 16(1):e13463. |
| [47] | ZHENG J, HU Y, XU H,et al. Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus-a multicenter study in China[J]. Cardiovasc Diabetol, 2023, 22(1):137. |
| [48] | LUO B, XU W, FENG L,et al. Association between visceral fat area and glycated hemoglobin in type 2 diabetics: a retrospective study[J]. Diabetes Metab Syndr Obes, 2023, 16:3295-3301. |
/
| 〈 |
|
〉 |
